Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02828644 · ClinicalTrials.gov registry record · NA

Software Treatment for Actively Reducing Severity of ADHD - Follow Up

A NA study of Attention Deficit Disorder With Hyperactivity, sponsored by Akili Interactive Labs.

Completed
Registry status
NA
Development phase
175
Enrollment target
15
Study locations

NCT02828644 is a NA study of Attention Deficit Disorder With Hyperactivity that has completed, run by Akili Interactive Labs. The registered enrollment target is 175 participants, below the 346-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (49% lower). The trial reports 15 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02828644, a NA study of Attention Deficit Disorder With Hyperactivity, has completed, sponsored by Akili Interactive Labs.

COMPLETED
Registry status
NA
Development phase
175 participants
Enrollment target
15
Study locations

Study Summary

This is an exploratory study to assess potential maintenance of clinical benefit (cognition and symptoms) following 4 weeks of at-home digital therapy in ADHD children.

Conditions Studied

Attention Deficit Disorder With Hyperactivity

Interventions

  • DEVICE EVO

Study Locations (15)

Florida

  • Florida Clinical Research Center, LLC - Bradenton
  • Florida Clinical Research Center, LLC - Bradenton
  • Meridien Research - Bradenton
  • Florida Clinical Research Center - Maitland

North Carolina

  • Duke Child and Family Study Center - Durham
  • Duke University - Durham
  • The Neuropsychiatric Clinic at Carolina Partners - Raleigh

California

  • Avida, Inc. - Newport Beach
  • University of California Davis MIND Institute - Sacramento

Arizona

  • Melmed Center - Scottsdale

Massachusetts

  • South Shore Psychiatric Services - Marshfield

Missouri

  • Midwest Research Group - Saint Charles

Nevada

  • Center for Psychiatry and Behavioral Medicine - Las Vegas

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 175 participants
Start Date 2016-08
Est. Completion 2018-02
Phase NA

Sponsor

Akili Interactive Labs

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02828644

The ClinicalTrials.gov registry entry for NCT02828644 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 346-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (49% lower). The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 1 intervention - of which EVO is the first listed.

NCT02828644 reports 15 study locations spanning 9 distinct geographic areas - top geographies include Florida, North Carolina, California.

Frequently Asked Questions

What is clinical trial NCT02828644 about?

NCT02828644 is a clinical study titled "Software Treatment for Actively Reducing Severity of ADHD - Follow Up". This is an exploratory study to assess potential maintenance of clinical benefit (cognition and symptoms) following 4 weeks of at-home digital therapy in ADHD children.

What is the current status of trial NCT02828644?

This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2016-08. Estimated completion is 2018-02.

What conditions does trial NCT02828644 study?

This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity.

What interventions are being tested in trial NCT02828644?

The interventions under investigation include: EVO (DEVICE).

Who is sponsoring clinical trial NCT02828644?

This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02828644 being conducted?

This trial has 15 study locations across Arizona, California, Florida, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Disorder With Hyperactivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Disorder With Hyperactivity

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.